Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(4):261-268; doi:10.1093/jnci/djh034
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (362)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Umar, A.
Right arrow Articles by Srivastava, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Umar, A.
Right arrow Articles by Srivastava, S.
Related Collections
Right arrowCorrespondence about this Article
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

COMMENTARY

Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability

Asad Umar, C. Richard Boland, Jonathan P. Terdiman, Sapna Syngal, Albert de la Chapelle, Josef Rüschoff, Richard Fishel, Noralane M. Lindor, Lawrence J. Burgart, Richard Hamelin, Stanley R. Hamilton, Robert A. Hiatt, Jeremy Jass, Annika Lindblom, Henry T. Lynch, Païvi Peltomaki, Scott D. Ramsey, Miguel A. Rodriguez-Bigas, Hans F. A. Vasen, Ernest T. Hawk, J. Carl Barrett, Andrew N. Freedman, Sudhir Srivastava

Affiliations of authors: Division of Cancer Prevention (AU, ETH, SS), Center for Cancer Research (JCB), Division of Cancer Control and Population Sciences (ANF), National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD; Division of Gastroenterology, Baylor University Medical Center, Dallas, TX (CRB); Department of Medicine (JPT), Comprehensive Cancer Center and School of Medicine (RAH), University of California at San Francisco; Dana-Farber Cancer Institute, Boston MA (SS); Comprehensive Cancer Center, The Ohio State University, Columbus, OH (ADLC); Institute of Pathology, Klinikum Kassel, Kassel, Germany (JR); Genetics and Molecular Biology Program, Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA (RF); Mayo Clinic Rochester, Rochester, MN (NML, LJB); Institut National de la Santé et de la Recherche Médicale, Unit 434, Centre d'Etudes du Polymorphisme Humain, Paris, France (RH); The University of Texas M. D. Anderson Cancer Center, Houston, TX (SRH, MARB); Department of Pathology, McGill University, Montreal, Quebec Canada (JJ); Department of Molecular Medicine, Clinical Genetics Unit, Karolinska Institutet, Stockholm, Sweden (AL); Department of Preventive Medicine, Creighton University, Omaha, NE (HTL); Department of Medical Genetics, University of Helsinki, Helsinki, Finland (PP); Fred Hutchinson Cancer Research Center, Seattle, WA (SDR); Foundation for the Detection of Hereditary Tumours, Leiden, The Netherlands (HFAV).

Correspondence to: Asad Umar, DVM, PhD, Division of Cancer Prevention, National Cancer Institute, 6130 Executive Blvd., EPN 2141, Bethesda, MD 20892 (e-mail: asad.umar{at}nih.gov)

Hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch syndrome, is a common autosomal dominant syndrome characterized by early age at onset, neoplastic lesions, and microsatellite instability (MSI). Because cancers with MSI account for approximately 15% of all colorectal cancers and because of the need for a better understanding of the clinical and histologic manifestations of HNPCC, the National Cancer Institute hosted an international workshop on HNPCC in 1996, which led to the development of the Bethesda Guidelines for the identification of individuals with HNPCC who should be tested for MSI. To consider revision and improvement of the Bethesda Guidelines, another HNPCC workshop was held at the National Cancer Institute in Bethesda, MD, in 2002. In this commentary, we summarize the Workshop presentations on HNPCC and MSI testing; present the issues relating to the performance, sensitivity, and specificity of the Bethesda Guidelines; outline the revised Bethesda Guidelines for identifying individuals at risk for HNPCC; and recommend criteria for MSI testing.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Correspondence about this Article

Re: Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
Luigi Laghi, Paolo Bianchi, Massimo Roncalli, and Alberto Malesci
J Natl Cancer Inst 2004 96: 1402-1403. [Extract] [Full Text] [PDF]

RESPONSE: Re: Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
Asad Umar
J Natl Cancer Inst 2004 96: 1403-1404. [Extract] [Full Text] [PDF]

Re: Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
Finlay Macrae and Marion Harris
J Natl Cancer Inst 2005 97: 936-937. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. N. Poynter, K. D. Siegmund, D. J. Weisenberger, T. I. Long, S. N. Thibodeau, N. Lindor, J. Young, M. A. Jenkins, J. L. Hopper, J. A. Baron, et al.
Molecular Characterization of MSI-H Colorectal Cancer by MLHI Promoter Methylation, Immunohistochemistry, and Mismatch Repair Germline Mutation Screening
Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3208 - 3215.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
D Ramsoekh, A Wagner, M E van Leerdam, W N M Dinjens, E W Steyerberg, D J J Halley, E J Kuipers, and D Dooijes
A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting
Gut, November 1, 2008; 57(11): 1539 - 1544.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. C. Haugen, A. Goel, K. Yamada, G. Marra, T.-P. Nguyen, T. Nagasaka, S. Kanazawa, J. Koike, Y. Kikuchi, X. Zhong, et al.
Genetic Instability Caused by Loss of MutS Homologue 3 in Human Colorectal Cancer
Cancer Res., October 15, 2008; 68(20): 8465 - 8472.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. T. Lynch, J. N. Marcus, and W. S. Rubinstein
Stemming the Tide of Cancer for BRCA1/2 Mutation Carriers
J. Clin. Oncol., September 10, 2008; 26(26): 4239 - 4243.
[Full Text] [PDF]


Home page
J. Med. Genet.Home page
J Balmana, F Balaguer, S Castellvi-Bel, E W Steyerberg, M Andreu, X Llor, R Jover, A Castells, S Syngal, and for the Gastrointestinal Oncology Group of the Spa
Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients
J. Med. Genet., September 1, 2008; 45(9): 557 - 563.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Wasielewski, H. Vasen, J. Wijnen, M. Hooning, D. Dooijes, C. Tops, J. G.M. Klijn, H. Meijers-Heijboer, and M. Schutte
CHEK2 1100delC Is a Susceptibility Allele for HNPCC-Related Colorectal Cancer
Clin. Cancer Res., August 1, 2008; 14(15): 4989 - 4994.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A.H.S. Gylling, T.T. Nieminen, W.M. Abdel-Rahman, K. Nuorva, M. Juhola, E.I. Joensuu, H.J. Jarvinen, J.-P. Mecklin, M. Aarnio, and P.T. Peltomaki
Differential cancer predisposition in Lynch syndrome: insights from molecular analysis of brain and urinary tract tumors
Carcinogenesis, July 1, 2008; 29(7): 1351 - 1359.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
J. Shia
Immunohistochemistry versus Microsatellite Instability Testing For Screening Colorectal Cancer Patients at Risk For Hereditary Nonpolyposis Colorectal Cancer Syndrome: Part I. The Utility of Immunohistochemistry
J. Mol. Diagn., July 1, 2008; 10(4): 293 - 300.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
L. Zhang
Immunohistochemistry versus Microsatellite Instability Testing for Screening Colorectal Cancer Patients at Risk for Hereditary Nonpolyposis Colorectal Cancer Syndrome: Part II. The Utility of Microsatellite Instability Testing
J. Mol. Diagn., July 1, 2008; 10(4): 301 - 307.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
C. Loddenkemper, D. Nagorsen, and M. Zeitz
Foxp3 and microsatellite stability phenotype in colorectal cancer
Gut, June 1, 2008; 57(6): 725 - 726.
[Full Text] [PDF]


Home page
GutHome page
S Le Gouvello, S Bastuji-Garin, N Aloulou, H Mansour, M-T Chaumette, F Berrehar, A Seikour, A Charachon, M Karoui, K Leroy, et al.
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas
Gut, June 1, 2008; 57(6): 772 - 779.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
M Clendenning, L Senter, H Hampel, K L. Robinson, S Sun, D Buchanan, M D Walsh, M Nilbert, J Green, J Potter, et al.
A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome
J. Med. Genet., June 1, 2008; 45(6): 340 - 345.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. H. Calderwood, D. Huo, and D. T. Rubin
Association Between Colorectal Cancer and Urologic Cancers
Arch Intern Med, May 12, 2008; 168(9): 1003 - 1009.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Suehiro, C. W. Wong, L. R. Chirieac, Y. Kondo, L. Shen, C. R. Webb, Y. W. Chan, A. S.Y. Chan, T. L. Chan, T.-T. Wu, et al.
Epigenetic-Genetic Interactions in the APC/WNT, RAS/RAF, and P53 Pathways in Colorectal Carcinoma
Clin. Cancer Res., May 1, 2008; 14(9): 2560 - 2569.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Imai and H. Yamamoto
Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics
Carcinogenesis, April 1, 2008; 29(4): 673 - 680.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. D. Walsh, M. C. Cummings, D. D. Buchanan, W. M. Dambacher, S. Arnold, D. McKeone, R. Byrnes, M. A. Barker, B. A. Leggett, M. Gattas, et al.
Molecular, Pathologic, and Clinical Features of Early-Onset Endometrial Cancer: Identifying Presumptive Lynch Syndrome Patients
Clin. Cancer Res., March 15, 2008; 14(6): 1692 - 1700.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
V. Deschoolmeester, M. Baay, W. Wuyts, E. Van Marck, N. Van Damme, P. Vermeulen, K. Lukaszuk, F. Lardon, and J. B. Vermorken
Detection of Microsatellite Instability in Colorectal Cancer Using an Alternative Multiplex Assay of Quasi-Monomorphic Mononucleotide Markers
J. Mol. Diagn., March 1, 2008; 10(2): 154 - 159.
[Abstract] [Full Text] [PDF]


Home page
Am Soc Clin Oncol Ed BookHome page
J. Balmana, E. W. Steyerberg, and S. Syngal
Risk Quantification for Carrying Mutations in Lynch Syndrome Genes
ASCO Educational Book, January 1, 2008; 2008(1): 59 - 64.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Kenyon and S. L. Gerson
The role of DNA damage repair in aging of adult stem cells
Nucleic Acids Res., December 26, 2007; (2007) gkm1064v1.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. H. Lu, J. O. Schorge, K. J. Rodabaugh, M. S. Daniels, C. C. Sun, P. T. Soliman, K. G. White, R. Luthra, D. M. Gershenson, and R. R. Broaddus
Prospective Determination of Prevalence of Lynch Syndrome in Young Women With Endometrial Cancer
J. Clin. Oncol., November 20, 2007; 25(33): 5158 - 5164.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
N. D. Kauff
How Should Women With Early-Onset Endometrial Cancer Be Evaluated for Lynch Syndrome?
J. Clin. Oncol., November 20, 2007; 25(33): 5143 - 5146.
[Full Text] [PDF]


Home page
Cancer Res.Home page
M. A. McIlhatton, J. Tyler, S. Burkholder, J. Ruschoff, B. Rigas, L. Kopelovich, and R. Fishel
Nitric Oxide Donating Aspirin Derivatives Suppress Microsatellite Instability in Mismatch Repair Deficient and Hereditary Nonpolyposis Colorectal Cancer Cells
Cancer Res., November 15, 2007; 67(22): 10966 - 10975.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. R. Turner, C. Li, and C. C. Compton
Newer Pathologic Assessment Techniques for Colorectal Carcinoma
Clin. Cancer Res., November 15, 2007; 13(22): 6871s - 6876s.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
D. Z. J. Chu, G. Gibson, D. David, and Y. Yen
The Surgeon's Role in Cancer Prevention. The Model in Colorectal Carcinoma
Ann. Surg. Oncol., November 1, 2007; 14(11): 3054 - 3069.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. K. Rustgi
The genetics of hereditary colon cancer
Genes & Dev., October 15, 2007; 21(20): 2525 - 2538.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. L. Manne, D. C. Chung, D. S. Weinberg, H. S. Vig, Z. Catts, M. K. Cabral, K. Shannon, and N. J. Meropol
Knowledge and Attitudes about Microsatellite Instability Testing among High-Risk Individuals Diagnosed with Colorectal Cancer
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2110 - 2117.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Hampel, J. Panescu, J. Lockman, K. Sotamaa, D. Fix, I. Comeras, J. LaJeunesse, H. Nakagawa, J. A. Westman, T. W. Prior, et al.
Comment on: Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer Patients
Cancer Res., October 1, 2007; 67(19): 9603 - 9603.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
L. C. Young, A. M. Keuling, R. Lai, P. N. Nation, V. A. Tron, and S. E. Andrew
The associated contributions of p53 and the DNA mismatch repair protein Msh6 to spontaneous tumorigenesis
Carcinogenesis, October 1, 2007; 28(10): 2131 - 2138.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. T. Campbell, M. Cotterchio, E. Dicks, P. Parfrey, S. Gallinger, and J. R. McLaughlin
Excess Body Weight and Colorectal Cancer Risk in Canada: Associations in Subgroups of Clinically Defined Familial Risk of Cancer
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1735 - 1744.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Castellvi-Bel, A. Castells, R. de Cid, J. Munoz, F. Balaguer, V. Gonzalo, C. Ruiz-Ponte, M. Andreu, X. Llor, R. Jover, et al.
Association of the ARLTS1 Cys148Arg variant with sporadic and familial colorectal cancer
Carcinogenesis, August 1, 2007; 28(8): 1687 - 1691.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
N. Khilko, P. Bourne, Qi Yang, and Ping Tang
Mismatch Repair Genes hMLH1 and hMSH2 May Not Play an Essential Role in Breast Carcinogenesis
International Journal of Surgical Pathology, July 1, 2007; 15(3): 233 - 241.
[Abstract] [PDF]


Home page
GutHome page
A Gylling, W M Abdel-Rahman, M Juhola, K Nuorva, E Hautala, H J Jarvinen, J-P Mecklin, M Aarnio, and P Peltomaki
Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study
Gut, July 1, 2007; 56(7): 926 - 933.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Malesci, L. Laghi, P. Bianchi, G. Delconte, A. Randolph, V. Torri, C. Carnaghi, R. Doci, R. Rosati, M. Montorsi, et al.
Reduced Likelihood of Metastases in Patients with Microsatellite-Unstable Colorectal Cancer
Clin. Cancer Res., July 1, 2007; 13(13): 3831 - 3839.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Bettstetter, S. Dechant, P. Ruemmele, M. Grabowski, G. Keller, E. Holinski-Feder, A. Hartmann, F. Hofstaedter, and W. Dietmaier
Distinction of Hereditary Nonpolyposis Colorectal Cancer and Sporadic Microsatellite-Unstable Colorectal Cancer through Quantification of MLH1 Methylation by Real-time PCR
Clin. Cancer Res., June 1, 2007; 13(11): 3221 - 3228.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
H F A Vasen, G Moslein, A Alonso, I Bernstein, L Bertario, I Blanco, J Burn, G Capella, C Engel, I Frayling, et al.
Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)
J. Med. Genet., June 1, 2007; 44(6): 353 - 362.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. J. Mead, M. A. Jenkins, J. Young, S. G. Royce, L. Smith, D. J. B. St. John, F. Macrae, G. G. Giles, J. L. Hopper, and M. C. Southey
Microsatellite Instability Markers for Identifying Early-Onset Colorectal Cancers Caused by Germ-Line Mutations in DNA Mismatch Repair Genes
Clin. Cancer Res., May 15, 2007; 13(10): 2865 - 2869.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. V. Seiden, D. Patel, M. J. O'Neill, and E. Oliva
Case 13-2007 -- A 46-Year-Old Woman with Gynecologic and Intestinal Cancers
N. Engl. J. Med., April 26, 2007; 356(17): 1760 - 1769.
[Full Text] [PDF]


Home page
JCOHome page
L. Valle, J. Perea, P. Carbonell, V. Fernandez, A. M. Dotor, J. Benitez, and M. Urioste
Clinicopathologic and Pedigree Differences in Amsterdam I-Positive Hereditary Nonpolyposis Colorectal Cancer Families According to Tumor Microsatellite Instability Status
J. Clin. Oncol., March 1, 2007; 25(7): 781 - 786.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
H. T. Lynch, J. F. Lynch, and P. M. Lynch
Toward a Consensus in Molecular Diagnosis of Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome)
J Natl Cancer Inst, February 21, 2007; 99(4): 261 - 263.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
K. Lagerstedt Robinson, T. Liu, J. Vandrovcova, B. Halvarsson, M. Clendenning, T. Frebourg, N. Papadopoulos, K. W. Kinzler, B. Vogelstein, P. Peltomaki, et al.
Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Diagnostics
J Natl Cancer Inst, February 21, 2007; 99(4): 291 - 299.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. M. Xicola, X. Llor, E. Pons, A. Castells, C. Alenda, V. Pinol, M. Andreu, S. Castellvi-Bel, A. Paya, R. Jover, et al.
Performance of Different Microsatellite Marker Panels for Detection of Mismatch Repair-Deficient Colorectal Tumors
J Natl Cancer Inst, February 7, 2007; 99(3): 244 - 252.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
R C Niessen, M J W Berends, Y Wu, R H Sijmons, H Hollema, M J L Ligtenberg, H E K de Walle, E G E de Vries, A Karrenbeld, C H C M Buys, et al.
Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer
Gut, December 1, 2006; 55(12): 1781 - 1788.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G. Y. Locker, S. Hamilton, J. Harris, J. M. Jessup, N. Kemeny, J. S. Macdonald, M. R. Somerfield, D. F. Hayes, and R. C. Bast Jr
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
J. Clin. Oncol., November 20, 2006; 24(33): 5313 - 5327.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. G. Guillem, W. C. Wood, J. F. Moley, A. Berchuck, B. Y. Karlan, D. G. Mutch, R. F. Gagel, J. Weitzel, M. Morrow, B. L. Weber, et al.
ASCO/SSO Review of Current Role of Risk-Reducing Surgery in Common Hereditary Cancer Syndromes
J. Clin. Oncol., October 1, 2006; 24(28): 4642 - 4660.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
J. G. Guillem, W. C. Wood, J. F. Moley, A. Berchuck, B. Y. Karlan, D. G. Mutch, R. F. Gagel, J. Weitzel, M. Morrow, B. L. Weber, et al.
ASCO/SSO Review of Current Role of Risk-Reducing Surgery in Common Hereditary Cancer Syndromes
Ann. Surg. Oncol., October 1, 2006; 13(10): 1296 - 1321.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. Balmana, D. H. Stockwell, E. W. Steyerberg, E. M. Stoffel, A. M. Deffenbaugh, J. E. Reid, B. Ward, T. Scholl, B. Hendrickson, J. Tazelaar, et al.
Prediction of MLH1 and MSH2 mutations in Lynch syndrome.
JAMA, September 27, 2006; 296(12): 1469 - 1478.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. Chen, W. Wang, S. Lee, K. Nafa, J. Lee, K. Romans, P. Watson, S. B. Gruber, D. Euhus, K. W. Kinzler, et al.
Prediction of germline mutations and cancer risk in the Lynch syndrome.
JAMA, September 27, 2006; 296(12): 1479 - 1487.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
N. M. Lindor, G. M. Petersen, D. W. Hadley, A. Y. Kinney, S. Miesfeldt, K. H. Lu, P. Lynch, W. Burke, and N. Press
Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.
JAMA, September 27, 2006; 296(12): 1507 - 1517.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. M. Ford and A. S. Whittemore
Predicting and preventing hereditary colorectal cancer.
JAMA, September 27, 2006; 296(12): 1521 - 1523.
[Full Text] [PDF]


Home page
Cancer Res.Home page
H. Hampel, W. Frankel, J. Panescu, J. Lockman, K. Sotamaa, D. Fix, I. Comeras, J. La Jeunesse, H. Nakagawa, J. A. Westman, et al.
Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer Patients.
Cancer Res., August 1, 2006; 66(15): 7810 - 7817.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
K. M. Murphy, S. Zhang, T. Geiger, M. J. Hafez, J. Bacher, K. D. Berg, and J. R. Eshleman
Comparison of the Microsatellite Instability Analysis System and the Bethesda Panel for the Determination of Microsatellite Instability in Colorectal Cancers
J. Mol. Diagn., July 1, 2006; 8(3): 305 - 311.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. A. Barnetson, A. Tenesa, S. M. Farrington, I. D. Nicholl, R. Cetnarskyj, M. E. Porteous, H. Campbell, and M. G. Dunlop
Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer.
N. Engl. J. Med., June 29, 2006; 354(26): 2751 - 2763.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Melloni, C. Doglioni, A. Bandiera, A. Carretta, P. Ciriaco, G. Arrigoni, and P. Zannini
Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma
Ann. Thorac. Surg., June 1, 2006; 81(6): 2008 - 2013.
[Abstract] [Full Text] [PDF]


Home page
Ann Oncol